Moderna, Inc. - Common Stock (NQ:MRNA)

189.95 -13.26 (-6.53%)

Delayed Quote Updated: 3:18 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

99 100 Next >

Wondering what's happening in today's S&P500 pre-market session? ↗

October 23, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.

Via Chartmill

Moderna to Host Investor Event - Analyst Day

October 23, 2025

Via ACCESS Newswire

Moderna Stock Slides After-Hours On CMV Vaccine Failure In Phase 3 Trial — Retail Traders Warn Of ‘Endless’ Cash Burn ↗

October 23, 2025

The biotech will continue testing the vaccine in bone marrow transplant patients, where CMV reactivation can cause serious complications, and said no safety concerns were identified.

Via Stocktwits

What's going on in today's after hours session: S&P500 movers ↗

October 22, 2025

Discover the top S&P500 movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Global Economic Freedom in Retreat: A Four-Year Decline Signals Looming Market Shifts

October 22, 2025

Washington D.C., October 22, 2025 – The world stands at a critical juncture as the 2025 Economic Freedom of the World index, prominently released by the Fraser Institute in collaboration with the Cato...

Via MarketMinute

Topics Bonds Brexit Economy

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint

October 22, 2025

Via ACCESS Newswire

Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why. ↗

October 22, 2025

The biotech's innovative qualities will come in handy.

Via The Motley Fool

Should You Buy Moderna Right Now? ↗

October 22, 2025

Shares could keep sliding, as Moderna's post-COVID pipeline has yet to reach a breakthrough.

Via The Motley Fool

Topics Bonds

Wellgistics And DataVault Team Up To Transform Prescription Tracking ↗

October 22, 2025

DataVault AI and Wellgistics Health are collaborating to bring blockchain technology to the US prescription drug market.

Via Benzinga

Topics Artificial Intelligence

These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall ↗

October 21, 2025

Don't try to catch a falling surgical knife.

Via The Motley Fool

Topics Government

Dow Jumps More Than 500 Points Ahead Of Earnings: Investor Fear Eases, Greed Index Remains In 'Fear' Zone ↗

October 21, 2025

U.S. stocks rise on Monday, with the Dow up 500+ points. Moderna and Cleveland-Cliffs report gains. Most S&P sectors close higher, with Fear & Greed Index at 30.3.

Via Benzinga

Topics Stocks

Small Caps Rally As Credit Fears Ease, Gold Rebounds To $4,350: What's Moving Markets Monday? ↗

October 20, 2025

Via Benzinga

What's going on in today's session: S&P500 movers ↗

October 20, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.

Via Chartmill

Stay informed with the top movers within the S&P500 index on Monday. ↗

October 20, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Stock Market Today: S&P 500, Nasdaq, Dow Jones Futures Rise— Micron, Bitmine, Coinbase In Focus ↗

October 20, 2025

U.S. stock futures rose on Monday following Friday’s advances. Futures of major benchmark indices were higher.

Via Benzinga

Topics Stocks

2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm

October 20, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts

October 19, 2025

The biotechnology sector is currently experiencing a significant surge in investor attention, characterized by a blend of cautious optimism and strategic focus. As of October 2025, this heightened...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025

October 19, 2025

Via ACCESS Newswire

Healthcare’s AI Revolution: Generative Intelligence Delivers Real Returns as Agentic Systems Drive Measurable Outcomes

October 17, 2025

The healthcare industry is experiencing a profound transformation, propelled by the accelerating adoption of artificial intelligence. While AI's potential has long been discussed, recent advancements...

Via TokenRing AI

Topics Artificial Intelligence Economy

Uncover the latest developments among S&P500 stocks in today's session. ↗

October 17, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

Via Chartmill

Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

October 16, 2025

Via ACCESS Newswire

Why Moderna Might Be a One-Hit Wonder ↗

October 15, 2025

Moderna's sales have plummeted in recent years along with diminishing demand for COVID vaccines.

Via The Motley Fool

Which S&P500 stocks are moving on Wednesday? ↗

October 15, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Wednesday's session: top gainers and losers in the S&P500 index ↗

October 15, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Government Shutdown Casts Long Shadow Over Economy and Interest Rate Outlook Ahead of Powell's Pivotal Speech

October 14, 2025

The United States government is currently in the throes of its third week of a shutdown, a fiscal impasse that commenced on October 1, 2025, following a congressional failure to enact appropriations...

Via MarketMinute

Topics Economy Government Regulatory Compliance

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential ↗

October 14, 2025

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least $5 billion.

Via Benzinga

David Gardner: 9 Foolish Truths I Hold to Be Self-Evident ↗

October 14, 2025

Whether you're well steeped in Foolishness or at the beginning stages of your investing journey, these are nine foundational truths not to be forgotten.

Via The Motley Fool

Moderna (MRNA) Stock Trades Up, Here Is Why

October 13, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped in the afternoon session after the company presented promising early data for its investigational cancer antigen therapy, mRNA-4359, from a...

Via StockStory

Topics Economy Government Stocks

Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients ↗

October 13, 2025

Moderna's Phase 1/2 study shows mRNA-4359 plus pembrolizumab yields 24% response rate and 60% disease control in resistant melanoma patients.

Via Benzinga

3 Cash-Burning Stocks with Warning Signs

October 13, 2025

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even...

Via StockStory

Topics Bankruptcy Cannabis

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.